IP Library Granted Patent US 11,027,049
Granted Patent B2
US 11,027,049 · App. 15/994,263 · Granted Jun 8, 2021

Devices and methods for delivery of bioactive agents

Inventors: Ralph A. Chappa (Ham Lake, MN); Andrew G. Bach (Edina, MN)
Assignee: Surmodics, Inc.
A61L29/085A61L29/16A61L2300/416A61L2300/60
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,027,049
App. No.
15/994,263
Granted
Jun 8, 2021
Kind
B2
Abstract

Embodiments of the invention include bioactive agent eluting devices. In an embodiment the invention includes a bioactive agent delivery device including a substrate, a hydrophilic polymer disposed on the substrate, and a substantially amorphous bioactive agent disposed on the surface of the hydrophilic polymer. In an embodiment, the invention includes a method of making a bioactive agent delivery device including depositing a hydrophilic polymer on a substrate forming a hydrophilic surface and depositing a substantially amorphous bioactive agent on the hydrophilic surface. In an embodiment, the invention includes a bioactive agent-eluting catheter including a catheter shaft and an expandable balloon disposed on the catheter shaft. Other embodiments are included herein.

Claims (22)

1. A bioactive agent delivery device comprising:

an expandable substrate forming part of a balloon;

a hydrophilic polymer layer disposed over the substrate, the hydrophilic polymer layer comprising a hydrophilic polymer comprising poly(ethylene glycol); and

a hydrophobic bioactive agent composition layer disposed over the surface of the hydrophilic polymer layer, the hydrophobic bioactive composition layer comprising one or more forms of paclitaxel; and

wherein the hydrophobic bioactive agent composition layer lacks the hydrophilic polymer.

2. The bioactive agent delivery device of claim 1 , the bioactive agent composition comprising trace amounts of a solvent that does not solvate the hydrophilic polymer layer.

3. The bioactive agent delivery device of claim 1 , further comprising a catheter shaft, wherein the expandable substrate forming part of the balloon is disposed on the catheter shaft.

4. The bioactive agent delivery device of claim 1 , wherein the hydrophilic polymer layer is covalently bonded to the expandable substrate through the reaction product of a latent photoreactive group.

5. The bioactive agent delivery device of claim 1 , the expandable substrate comprising an elastomeric material.

6. The bioactive agent delivery device of claim 1 , the expandable substrate comprising a polyamide.

7. The bioactive agent delivery device of claim 1 , wherein the thickness of the expandable substrate is from 5 μm to 100 μm.

8. The bioactive agent delivery device of claim 1 , wherein the hydrophilic polymer layer is cross-linked through the reaction product of a latent photoreactive group.

9. The bioactive agent delivery device of claim 1 , wherein the paclitaxel releases from the device into an aqueous environment in under 30 seconds when exposed to an aqueous environment.

10. The bioactive agent delivery device of claim 1 , wherein the paclitaxel is present in the hydrophobic bioactive composition layer in crystalline and amorphous forms.

11. A bioactive agent-eluting catheter comprising:

a catheter shaft;

an expandable balloon disposed on the catheter shaft, the expandable balloon comprising an expandable substrate; and

a hydrophilic polymer layer disposed over the substrate, the hydrophilic polymer layer comprising a hydrophilic polymer comprising poly(ethylene glycol);

a hydrophobic bioactive agent composition layer disposed over the surface of the hydrophilic polymer layer, the hydrophobic bioactive composition layer comprising one or more forms of paclitaxel; and

wherein the hydrophobic bioactive agent composition layer lacks the hydrophilic polymer.

12. The bioactive agent-eluting catheter of claim 11 , wherein the paclitaxel is present in the hydrophobic bioactive composition layer in crystalline and amorphous forms.

13. The bioactive agent-eluting catheter of claim 11 , wherein the paclitaxel releases from the device into an aqueous environment in under 30 seconds when exposed to an aqueous environment.

Assignments (5)
SECURITY INTEREST Recorded Jan 21, 2026
From: SURMODICS COATINGS, LLC
To: BANK OF MONTREAL, AS COLLATERAL AGENT
Reel/Frame 074461/0162 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2025
From: SURMODICS, INC.
To: SURMODICS COATINGS, LLC
Reel/Frame 073928/0178 →
RELEASE OF SECURITY INTEREST Recorded Nov 24, 2025
From: MIDCAP FUNDING IV TRUST
To: SURMODICS, INC.; SURMODICS SHARED SERVICES, LLC; SURMODICS HOLDINGS, LLC; SURMODICS COATINGS, LLC; SURMODICS MD, LLC; SURMODICS COATINGS MFG, LLC; SURMODICS IVD, INC.; SURMODICS MD OPERATIONS, LLC; NORMEDIX, INC.
Reel/Frame 073690/0186 →
SECURITY INTEREST Recorded Aug 23, 2024
From: SURMODICS, INC.; SURMODICS SHARED SERVICES, LLC; SURMODICS HOLDINGS, LLC; SURMODICS COATINGS, LLC; SURMODICS MD, LLC; SURMODICS COATINGS MFG, LLC; SURMODICS IVD, INC.; SURMODICS MD OPERATIONS, LLC; NORMEDIX, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 068762/0423 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2018
From: CHAPPA, RALPH A.; BACH, ANDREW G.
To: SURMODICS, INC.
Reel/Frame 046174/0424 →
Continuity (3)
Continuation 12769127 · Apr 28, 2010
Provisional Application 61173462 · Apr 28, 2009
Related Publication 20180272040A1 · Sep 27, 2018